HCPCS codes

63646 HCPCS codes with hospital pricing data in the network.

Sorted by number of hospitals reporting each code, most first.

• HCPCS A2011 — Supra sdrm, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS C8900 — MRA W/CONT ABD (48 hospitals)
• HCPCS C8901 — MRA W/O CONT ABD (48 hospitals)
• HCPCS C8902 — MRA W/O FOL W/CONT ABD (48 hospitals)
• HCPCS C8908 — MRI WO FOL W/CON BRST BI (48 hospitals)
• HCPCS C8909 — MRA W/CONT CHEST (48 hospitals)
• HCPCS C8910 — MRA W/O CONT CHEST (48 hospitals)
• HCPCS C8911 — MRA W/O FOL W/CONT CHEST (48 hospitals)
• HCPCS C8914 — MRA WO W CONT LWR EXT LT (48 hospitals)
• HCPCS C8918 — MRA W/CONT PELVIS (48 hospitals)
• HCPCS C8919 — MRA W/O CONT PELVIS (48 hospitals)
• HCPCS C8920 — MRA WO FOL W CONT PELVIS (48 hospitals)
• HCPCS G0278 — Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes posi UNSCHEDULED (48 hospitals)
• HCPCS G0283 — Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care (48 hospitals)
• HCPCS J0165 — EPI NOS 1 MG INJ (48 hospitals)
• HCPCS J2312 — NALOX NOS 0.4MG INJ (48 hospitals)
• HCPCS J3373 — VANCO 500 MG INJ (48 hospitals)
• HCPCS J3490 — EPHEDRINE 50 MG INJ (48 hospitals)
• HCPCS J3590 — TISSEEL 4 ML TOPICAL (48 hospitals)
• HCPCS J8499 — RITONAVIR 100 MG PO (48 hospitals)
• HCPCS J8999 — ERLOTINIB 150 MG PO (48 hospitals)
• HCPCS J9289 — Injection, nivolumab, 2 mg and hyaluronidase-nvhy (48 hospitals)
• HCPCS A2032 — MYRIAD MATRIX PER SQCM (48 hospitals)
• HCPCS A2033 — MYRIAD MORCELLS 4MG (48 hospitals)
• HCPCS C8903 — MRI W/CONT BREAST UNI LT (48 hospitals)
• HCPCS G0219 — Pet imaging whole body; melanoma for non-covered indications (48 hospitals)
• HCPCS G0252 — Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes) (48 hospitals)
• HCPCS G0281 — Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable (48 hospitals)
• HCPCS J0525 — Injection, cefotetan disodium, 10 mg (48 hospitals)
• HCPCS J0616 — METOPROLOL 5 MG INJ (48 hospitals)
• HCPCS J0618 — CALCIUM CHL 1 G INJ (48 hospitals)
• HCPCS J0668 — Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg (48 hospitals)
• HCPCS J0675 — CARBOPROST 0.25MG INJ (48 hospitals)
• HCPCS J0759 — Injection, clevidipine butyrate, 1 mg (48 hospitals)
• HCPCS J1163 — DILTIAZEM 25 MG INJ (48 hospitals)
• HCPCS J1299 — Injection, eculizumab, 2 mg (48 hospitals)
• HCPCS J1807 — Injection, ethacrynate sodium, 1 mg (48 hospitals)
• HCPCS J1938 — FUROSEMIDE 40 MG INJ (48 hospitals)
• HCPCS J2151 — MANNITOL 12.5G INJ (48 hospitals)
• HCPCS J3290 — TRANEXAMIC 1000MG INJ (48 hospitals)
• HCPCS J3535 — TIOTROPIUM 18 MCG 1CAP (48 hospitals)
• HCPCS J9220 — Injection, indigotindisulfonate sodium, 1 mg (48 hospitals)
• HCPCS J9342 — Injection, thiotepa, not otherwise specified, 1 mg (48 hospitals)
• HCPCS J9999 — CARMUSTINE WAFERS 8/BOX (48 hospitals)
• HCPCS Q4142 — Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS Q4345 — Matrix hd allograft dermis, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS G0463 — Hospital outpatient clinic visit for assessment and management of a patient UNSCHEDULED (48 hospitals)
• HCPCS H0049 — Alcohol and/or drug screening (48 hospitals)
• HCPCS J0162 — Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg (48 hospitals)
• HCPCS J0168 — Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg (48 hospitals)